Transcript
A (0:00)
How many people that are out there that are taking these drugs have transformed, transcend and changed their entire lives. You're taking a person that's completely overweight, not confident on the risk of type 2 diabetes. If not, they already have it. Heart disease, inflammation, knees, everything. They can't live the life they want and they end up getting on these drugs and they're life saving. I've taken guys £300, made them £200. I've taken people that have got their life back. Foreign.
B (0:30)
Guys got Phil here in Las Vegas. This man is crushing it right now. Brought out the nice watch, too. Let's go, baby. Bring a little something myself.
A (0:38)
There you go. Ap.
B (0:39)
Yes, sir.
A (0:39)
I love it.
B (0:40)
What's new with you though, man? You're busy these days?
A (0:42)
I'm busy. Vita Bella has been killing it. You know, we've been on a couple of big podcasts lately. We launched bringing Alphas Back, you know, free testosterone for. For men across the country, for all members. And we've been having a lot of fun, man.
B (0:57)
Ye came across you from Bradley show, actually.
A (0:59)
Yeah.
B (0:59)
Who's now going to be working with you. I don't know if you announced the app.
A (1:01)
Yeah, no, Brad. Brad's going to be having a lot of fun with us. He's good. We'd probably be on Brad again here soon, but that was a fun podcast.
B (1:08)
Let's go. Yeah. A lot of guys are in need of what you're selling. Could you, I guess, first off, explain what Vita Bella is for people that don't know?
A (1:16)
Yeah. Vita BELLA is a 40 state health and hormone company. It's membership driven. So you get a membership to the company. It's $129 a month. We include your TRT, we include doctor's visits, we include access to a war chest of medications, all your peptides, sexual wellness, hair loss, I mean, so many different things. And then bleeding edge therapies, like it's, it's the disruptor. I mean, people hate us, right, in the industry, but patients love us and we've grown so fast and it's hyperscaling as we speak.
